...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery.
【24h】

Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery.

机译:在喉部局部晚期癌中比较放疗和手术的治疗结果:比较仅限于符合手术条件的患者。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The use of radical radiotherapy and surgery for salvage (RRSS) in locally advanced squamous cell carcinoma (SCC) of the larynx is controversial. In the absence of randomized studies, it is unclear if RRSS can match the rates of locoregional control and survival reported for primary surgery in this setting. The aim of this study was to compare treatment outcomes of radiotherapy and surgery in comparable patients with CS III-IV SCC of the larynx. METHODS AND MATERIALS: Eighty-two patients with untreated T2N+M0 or T3T4NM0 SCC of the larynx were treated with a policy RRSS at the Toronto-Sunnybrook Regional Cancer Centre between June 1980 and December 1990. The medical records at presentation were reviewed independently by a panel of three surgical oncologists blinded as to treatment outcome to determine patient suitability for laryngectomy and neck dissection using eligibility criteria adopted by recent clinical trials. Treatment outcomes for surgery-eligible patients were compared to results of comparably staged patients in the surgical literature since 1980. RESULTS: Sixty-three patients (77%) were eligible for study. With a median follow-up of 3 years, radiotherapy controlled the primary in 8/20 evaluable glottic primaries and 21/41 evaluable supraglottic primaries. Forty-five percent of patients surviving 5 years retained a functional larynx. Sixteen of 29 relapsing patients were salvaged with surgery. Disease above the clavicles was controlled in 65% of T3T4N0N+ glottic primaries (compared to a published range of 53% to 79%) and 82% of T3N0 glottic primaries (compared to a published range of 69% to 84%). The 5-year overall survival of patients with T3T4 glottic cancer was 54% compared to a published range of 50% to 63%. The cause-specific survival (CSS) of patients with T3N0 glottic primaries (86% at 1 year and 73% at 2 years) was identical to the only published report of CSS in the surgical literature. CONCLUSION: A policy of RRSS offers a good chance of laryngeal conservation without compromising ultimate locoregional control or survival when compared to primary laryngectomy and neck dissection in patients with locally advanced carcinoma of the larynx meeting the surgical eligibility of clinical trials.
机译:目的:在喉部局部晚期鳞状细胞癌(SCC)中使用根治性放射治疗和手术进行抢救(RRSS)是有争议的。在缺乏随机研究的情况下,目前尚不清楚RRSS是否可以与这种情况下初次手术报道的局部控制率和生存率相匹配。这项研究的目的是比较可比的喉部CS III-IV SCC患者的放疗和手术治疗结果。方法和材料:1980年6月至1990年12月,在多伦多-桑尼布鲁克地区癌症中心对882例未经治疗的T2N + M0或T3T4NM0喉鳞癌的患者进行了RRSS政策治疗。由三名外科手术肿瘤学家组成的小组根据近期临床试验采用的资格标准,无法确定治疗结果是否适合喉镜和颈淋巴清扫术。自1980年以来,将符合手术条件的患者的治疗结果与手术文献中相对分期的患者的结果进行比较。结果:63例患者(占77%)符合研究条件。中位随访期为3年,放疗控制了8/20可评估声门原发和21/41可评估声门上原发的原发灶。存活5年的患者中有45%保留了功能性喉。 29名复发患者中有16名接受了手术治疗。锁骨上方的疾病在65%的T3T4N0N +声门原发中得到控制(相对于公开范围的53%至79%)和82%的T3N0声门原发性疾病(相对于公开的69%至84%范围)。 T3T4声门癌患者的5年总生存率为54%,而已发表的范围为50%至63%。 T3N0声门型原发患者的病因特异性生存(CSS)(1年时为86%,2年时为73%)与外科文献中唯一发表的CSS报道相同。结论:相对于符合临床试验手术条件的喉部晚期癌患者,与初次喉切除和颈淋巴结清扫术相比,RRSS的策略在不影响最终局部控制或生存的前提下,提供了良好的喉部保留机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号